| Literature DB >> 20153332 |
Martina L Jones1, Therese Seldon, Matthew Smede, Ashleigh Linville, David Y Chin, Ross Barnard, Stephen M Mahler, David Munster, Derek Hart, Peter P Gray, Trent P Munro.
Abstract
Recombinant monoclonal antibodies currently dominate the protein biologics marketplace. The path from target antigen discovery and screening, to a recombinant therapeutic antibody can be time-consuming and laborious. We describe a set of expression vectors, termed mAbXpress, that enable rapid and sequence-independent insertion of antibody variable regions into human constant region backbones. This method takes advantage of the In Fusion cloning system from Clontech, which allows ligation-free, high-efficiency insertion of the variable region cassette without the addition of extraneous amino acids. These modular vectors simplify the antibody reformatting process during the preliminary evaluation of therapeutic or diagnostic candidates. The resulting constructs can be used directly for transient or amplifiable, stable expression in mammalian cells. The effectiveness of this method was demonstrated by the creation of a functional, fully human anti-human CD83 monoclonal antibody. 2010. Published by Elsevier B.V. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20153332 DOI： 10.1016/j.jim.2010.02.001
Source DB: PubMed Journal: J Immunol Methods ISSN： 0022-1759 Impact factor: 2.303